Remove 2001 Remove Conditions Remove Epilepsy Remove Treatment
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).

Law 137
article thumbnail

Pushing Cannabis into Modern Healthcare

CannaTech

Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Changing Cannabis Conversations Worldwide.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. The pharmaceutical industry would likely have significant opportunities to develop new cannabinoid-based drugs for a multitude of medical conditions now being addressed by medical marijuana. as a Schedule II substance. marijuana companies.

article thumbnail

Serbian Patients Face Jail as Medical Marijuana Legalisation Stalls. so far 20 have gone to jail

Cannabis Law Report

Balkan Insight is reporting… eople with long-term illnesses are still being given prison sentences in Serbia for using cannabis to treat medical conditions, as the government has been stalling on legal reform while vowing even harsher anti-drug enforcement. I tried standard medicine, but there wasn’t much of a result.

Patients 105
article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Refractory paediatric epilepsy. Spasticity from neurological conditions.

article thumbnail

Here’s What Neuroimaging Can Tell Us About the Psychedelic Experience

SpeedWeed

Due to it’s high temporal value, EEG shines at detecting epilepsy, sleep disorders, dementia and any other structural brain disease or disorder. This technique remained the dominant perspective within neuroscience until 2001 by a stroke of genius from neurologist Marcus Raichle.